Similar Articles
1251 Effects of an oral iron chelator, deferasirox, on advanced hepatocellular carcinoma
1252 Isolated hepatic perfusion for unresectable hepatic malignancies: A systematic review and meta-analysis
1253 Cyclooxygenase-2 expression is associated with initiation of hepatocellular carcinoma, while prostaglandin receptor-1 expression predicts survival
1254 Lycopene modulates cellular proliferation, glycolysis and hepatic ultrastructure during hepatocellular carcinoma
1255 Polymorphisms of folate metabolism genes in patients with cirrhosis and hepatocellular carcinoma
1256 Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012
1257 Granulocyte colony-stimulating factor-producing hepatocellular carcinoma with abrupt changes
1258 Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma
1259 Hepatocellular carcinoma in patients with non-alcoholic fatty liver disease
1260 Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA